Clinical Trials Browser

Phase 1 × INDUSTRY × Neoplastic Cells, Circulating × Clear all

NCT02412462 2017-06-28

Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy

Phase 1 Completed

Neoplastic Cells, Circulating, Neoplasm Metastasis